Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Celgene Corporation (CELG $108.24)
-
Bristol-Myers Squibb Company (BMY $42.82)
- $42.82 P/E (TTM): 17.43X Cap: $87.15B
- View BMY Profile
- View Questions on BMY
Q: Good morning team, with my celg shares gone, replaced with bmy and bmy.rt , my question is what to do with the bmy rights. Sell , hold or what will they may be worth in the future? Any thoughts?
Thanks, Michael
Thanks, Michael
-
Amgen Inc. (AMGN $292.09)
- $292.09 P/E (TTM): 23.79X Cap: $157.25B
- View AMGN Profile
- View Questions on AMGN
-
Biogen Inc. (BIIB $149.13)
- $149.13 P/E (TTM): 14.4X Cap: $21.86B
- View BIIB Profile
- View Questions on BIIB
-
Celgene Corporation (CELG $108.24)
Q: Which biopharma company is the “Best of Breed” to hold for at least 10 years. I am focused on total return over the holding period rather than dividend yield. Also please provide your views on Biogen, Amgen and Celgene. Thanks,
-
Amgen Inc. (AMGN $292.09)
- $292.09 P/E (TTM): 23.79X Cap: $157.25B
- View AMGN Profile
- View Questions on AMGN
-
Celgene Corporation (CELG $108.24)
-
Merck & Company Inc. (MRK $87.03)
- $87.03 P/E (TTM): 13.57X Cap: $217.38B
- View MRK Profile
- View Questions on MRK
-
Pfizer Inc. (PFE $24.50)
- $24.50 P/E (TTM): 13.18X Cap: $139.29B
- View PFE Profile
- View Questions on PFE
Q: Based on my portfolio review, I need to increase my pharmaceutical weighing. Although you do not follow US companies closely, could you give me your best recommendations for 3 US pharmaceutical Companies. My only holding at the moment is Pfizer. Could you give me your opinion on this company please?
Insiders
Share Information
SEC Filings
News and Media